181 related articles for article (PubMed ID: 37415148)
1. Isolated adrenocorticotropic hormone deficiency following immune checkpoint inhibitors treatment often occurs in polyglandular endocrinopathies.
Chen H; Zhang L; Zhao L; Li X
BMC Endocr Disord; 2023 Jul; 23(1):139. PubMed ID: 37415148
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review.
Wang F; Shi X; Yu X; Yang Y
Front Endocrinol (Lausanne); 2024; 15():1326684. PubMed ID: 38318292
[TBL] [Abstract][Full Text] [Related]
3. Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors.
Kobayashi T; Iwama S; Sugiyama D; Yasuda Y; Okuji T; Ito M; Ito S; Sugiyama M; Onoue T; Takagi H; Hagiwara D; Ito Y; Suga H; Banno R; Nishikawa H; Arima H
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011534
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors and adrenal insufficiency: a large-sample case series study.
Cui K; Wang Z; Zhang Q; Zhang X
Ann Transl Med; 2022 Mar; 10(5):251. PubMed ID: 35402601
[TBL] [Abstract][Full Text] [Related]
5. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.
Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT
BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy-induced isolated ACTH deficiency in cancer therapy.
Iglesias P; Peiró I; Biagetti B; Paja-Fano M; Cobo DA; García Gómez C; Mateu-Salat M; Genua I; Majem M; Riudavets M; Gavira J; Lamas C; Fernández Pombo A; Guerrero-Pérez F; Villabona C; Cabezas Agrícola JM; Webb SM; Díez JJ
Endocr Relat Cancer; 2021 Oct; 28(12):783-792. PubMed ID: 34609950
[TBL] [Abstract][Full Text] [Related]
7. Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review.
Iglesias P; Sánchez JC; Díez JJ
Pituitary; 2021 Aug; 24(4):630-643. PubMed ID: 33761049
[TBL] [Abstract][Full Text] [Related]
8. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
[TBL] [Abstract][Full Text] [Related]
9. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
Gu YC; Liu Y; Xie C; Cao BS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.
Tan MH; Iyengar R; Mizokami-Stout K; Yentz S; MacEachern MP; Shen LY; Redman B; Gianchandani R
Clin Diabetes Endocrinol; 2019; 5():1. PubMed ID: 30693099
[TBL] [Abstract][Full Text] [Related]
11. Isolated autoimmune adrenocorticotropic hormone deficiency: From a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors.
Percik R; Shlomai G; Tirosh A; Tirosh A; Leibowitz-Amit R; Eshet Y; Greenberg G; Merlinsky A; Barhod E; Steinberg-Silman Y; Sella T
Autoimmun Rev; 2020 Feb; 19(2):102454. PubMed ID: 31838158
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Inhibitor-related New-onset Thyroid Dysfunction: A Retrospective Analysis Using the US FDA Adverse Event Reporting System.
Lu D; Yao J; Yuan G; Gao Y; Zhang J; Guo X
Oncologist; 2022 Mar; 27(2):e126-e132. PubMed ID: 35641200
[TBL] [Abstract][Full Text] [Related]
13. HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency.
Ono M; Fukuda I; Nagao M; Tomiyama K; Okazaki-Hada M; Shuto Y; Kobayashi S; Yamaguchi Y; Nagamine T; Nakajima Y; Inagaki-Tanimura K; Sugihara H
Pituitary; 2022 Aug; 25(4):615-621. PubMed ID: 35653047
[TBL] [Abstract][Full Text] [Related]
14. Isolated Adrenocorticotropic Hormone Deficiency and Primary Hypothyroidism in a Patient Undergoing Long-Term Hemodialysis: A Case Report and Literature Review.
Ohara N; Kobayashi M; Tuchida M; Koda R; Yoneoka Y; Iino N
Am J Case Rep; 2020 Apr; 21():e922376. PubMed ID: 32343680
[TBL] [Abstract][Full Text] [Related]
15. Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival.
Johnson J; Goldner W; Abdallah D; Qiu F; Ganti AK; Kotwal A
J Natl Compr Canc Netw; 2023 Feb; 21(3):281-287. PubMed ID: 36828029
[TBL] [Abstract][Full Text] [Related]
16. Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's Thyroiditis.
Mosaferi T; Tsai K; Sovich S; Wilhalme H; Kathuria-Prakash N; Praw SS; Drakaki A; Angell TE; Lechner MG
Thyroid; 2022 May; 32(5):496-504. PubMed ID: 35199588
[No Abstract] [Full Text] [Related]
17. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system.
Zhai Y; Ye X; Hu F; Xu J; Guo X; Zhuang Y; He J
J Immunother Cancer; 2019 Nov; 7(1):286. PubMed ID: 31694698
[TBL] [Abstract][Full Text] [Related]
18. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
19. Endocrinopathies Associated With Immune Checkpoint Inhibitor Use.
Kotwal A; Kennedy R; Kikani N; Thosani S; Goldner W; Shariff A
Endocr Pract; 2024 Jun; 30(6):584-591. PubMed ID: 38554775
[TBL] [Abstract][Full Text] [Related]
20. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]